Tianjin, China

Xiaowen Ren

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Xiaowen Ren in the Field of Medicine

Introduction

Xiaowen Ren is a prominent inventor based in Tianjin, China, noted for his significant contributions to the field of medicine. With a focus on developing innovative solutions for diseases related to inflammation, immunity, and infection, Xiaowen has demonstrated a commitment to advancing medical research and therapeutic applications.

Latest Patents

Xiaowen Ren holds one patent, titled "Glycyrrhetinic acid-30-amide derivatives and their use." This invention is crucial as it pertains to medical advancements, particularly in creating pharmaceutical compositions that exhibit anti-inflammatory, analgesic, anti-allergic, cough-preventive, liver-protecting, and anti-viral properties. The derivatives outlined in the patent are represented by a specific general formula and include details on their preparation and application.

Career Highlights

He is currently employed at the Tianjin Institute of Pharmaceutical Research, where he collaborates with a dedicated team on various projects aimed at enhancing therapeutic methods. Xiaowen's expertise and innovation in the field are highly regarded, and his work has significant implications for medical treatments and patient care.

Collaborations

Throughout his career, Xiaowen has partnered with esteemed colleagues, including Jianwu Wang and Weiren Xu. Their collaborative efforts contribute to a dynamic research environment that fosters innovation and the development of new medical therapies.

Conclusion

Inventor Xiaowen Ren exemplifies the spirit of innovation in the pharmaceutical field. With his patent on glycyrrhetinic acid derivatives, he plays a crucial role in advancing treatment options for various diseases. His contributions at the Tianjin Institute of Pharmaceutical Research and collaborations with fellow researchers underscore his commitment to enhancing medical science and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…